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Abstract 
Vaccines based on the strain Sofjin of the Far-Eastern tick-borne encephalitis virus (TBEV) subtype have been used for 
TBE prophylaxis for over 50 years in Russia and neighboring countries. On the wide territory, where all known TBEV 
subtypes are circulating, the cultural, purified, concentrated, inactivated TBE vaccine Moscow has been shown to be 
safe and efficacious in a massive immunization. In the present work, we describe the genome of the vaccine strain 
Sofjin. We have shown that it differs from TBEV strains previously published with the name “Sofjin”. Moreover, we have 
shown the stability of the virus during the vaccine manufacturing process on the molecular level.
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Background
The tick-borne encephalitis virus (TBEV) affects many 
people in Eurasia, causing about 10,000 cases annually. 
TBEV belongs to the Flavivirus genus. Its enveloped 
virion is covered by membrane-linked glycoprotein E 
and protein M underlying protein E. This protein-mem-
brane cage encloses genomic RNA packed with protein 
C (Lindenbach et  al. 2013). TBEV is divided into three 
subtypes: European, Siberian, and Far-Eastern (King et al. 
2012), and two newly described groups of TBEV strains 
are different from each other and from other genotypes 
(Demina et al. 2010).
TBEV strain Sofjin was isolated from the brain of 
a patient with acute TBE in Primorskiy kray in 1937 
(Smorodintseff et al. 1941), and was used for the produc-
tion of the TBE vaccine in Moscow (FSUE Manufacture 
of Bacterial and Viral Preparations of Chumakov Institute 
of Poliomyelitis and Viral Encephalitides, FSUE IPVE, 
Russia) for over 50 years. Starting in the 1960s, the inac-
tivated vaccine was prepared from the cultural fluid of 
chicken embryo fibroblasts (CEF), and, since 1982, over 
33,000,000 doses of the concentrated inactivated lyophi-
lized vaccine have been distributed.
In 1986, the genome fragment, encoding proteins C, 
M and E, of the TBEV strain Sofjin, was sequenced (Plet-
nev et  al. 1986). The complete genome sequence was 
presented only in (Pletnev et  al. 1990). Over the next 
20 years, more sequences appeared, describing the nucle-
otide composition of the strains called Sofjin (Kovalev 
et  al. 2012), drastically differing one sequence from one 
another. This fact arouses the necessity for the descrip-
tion of the strain Sofjin particularly used for the TBE vac-
cine produced in Moscow.
Currently, two preparations of the TBE vaccine Mos-
cow from TBEV strain Sofjin, produced by FSUE IPVE, 
are used for preventive vaccination against TBE: a cul-
tural, purified, concentrated, inactivated, lyophilized 
vaccine for the vaccination of children 3 years of age and 
up, and a cultural, purified, concentrated, inactivated, 
suspension adsorbed vaccine “Tick-E-Vac”, for children 
from 1 to 16 years at a dose of 0.25 ml, and for persons 
16-years-old and up in a dose of 0.5 ml. Both preparations 
are manufactured by similar technological processes.
In 1962 the TBEV strain Sofjin was provided by 
M.P. Chumakov’s laboratory to the FSUE IPVE to be used 
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as a master seed bank for the vaccine. The master seed 
bank was multiplied twice in 1977 and 1985 via the pas-
sage through a mouse brain of TBEV strain Sofjin, then 
aliquoted and stored. Nowadays, during the technologi-
cal process, one aliquot from the master seed bank (from 
1985) is multiplied 2–3 times in a mouse brain (working 
seed bank), and then multiplied in a CEF (non-concen-
trated bulk). Non-concentrated bulks are being inacti-
vated with formaldehyde, concentrated via ultrafiltration, 
and purified through gel-filtration and protamine sulfate 
to obtain an inactivated vaccine lot.
We obtained complete genome sequences for a master 
seed bank and working seed bank viruses, and sequences 
of structural parts of the genomes of non-concentrated 
bulk viruses. Viral RNA was extracted from mice brain 
suspensions or CEF culture supernatants with TRIRea-
gent LS (Sigma-Aldrich), and, after RT-PCR with over-
lapping sets of specific primers (sequences available upon 
request), M-MLV reverse transcriptase (Promega) and 
Taq-polymerase (Fermentas), was sequenced directly 
from PCR-DNA on the ABI PRISM 3730 sequencer using 
ABI PRISM® BigDye™ Terminator v. 3.1.
The master seed bank nucleotide sequence of the 
genome fragment, encoding the whole polyprotein, 
was deposited into GenBank (ID KC806252), and the 
sequence was named “Sofjin-Chumakov” to differentiate 
it from the other strains with the same name deposited to 
the GenBank previously.
We performed a phylogenetic analysis with Clustal-
X 2.0.11 (Larkin et  al. 2007) of Sofjin-Chumakov and 
GenBank complete genome sequences of TBEV strains, 
including several “Sofjin” strains (Fig.  1). The Far-East-
ern subtype showed several clusters. All “Sofjin” strains 
belonged to a group with several strains from the Urals, 
Primorskiy kray and Irkutsk region (Russia).
The phylogenetic analysis of GenBank nucleotide 
sequences of protein E encoding genome fragments of 
Far-Eastern TBEV strains (Fig. 2) showed, as mentioned 
previously (Kovalev et  al. 2012), that ‘Sofjin’ strains did 
not form a distinct branch on this tree. The E protein 
sequence of Sofjin-Chumakov was identical to the one 
of the TBEV strain SofjinKGG (Kozlovskaya et al. 2010). 
This strain has been used as the Sofjin strain in Chu-
makov IPVE for many years.
Strain SofjinKSY_JF819648 (D.I.  Ivanovsky Institute of 
Virology) (Kovalev et al. 2012) contained only five nucle-
otide substitutions to the Sofjin-Chumakov sequence. 
Possibly, these differences could be the result of different 
passage histories of these viruses.
Sofjin-Chumakov showed the greatest number of dif-
ferences with strain Sofjin-HO, sequenced by Japanese 
authors, which was more related to the Khabarovsk strains.
Sequences Sofjin_X07755 and Sofjin-P-Chimera_
FJ828987 were almost identical to Sofjin-Ru_JN229223. 
Sofjin-P-Chimera was made using plasmid, prepared by 
Dobrikova and Pletnev (Dobrikova and Pletnev 1995) 
from the Sofjin strain, and sequenced by Pletnev’s team 
(Pletnev et  al. 1986, 1990). Sofjin-Ru is a virus revived 
in  vitro from the same plasmid. These three viruses, 
along with Sofjin_JX498940 (NSC ‘Vector’), formed a dis-
tinct cluster.
Sequence SofjinVM2001_JF819650 showed a sig-
nificant difference from the sequence Sofjin-Chu-
makov, despite the fact that its authors claimed it to be 
sequenced from a drugstore-bought vial of TBE vaccine 
Moscow (Kovalev et al. 2012). It could be due to formalin 
inactivation damage to the viral RNA that finally caused 
various nucleotide mismatches during RT-PCR reactions 
before sequencing or any other laboratory artifacts.
We showed that the sequences of the virus on all stages 
of the vaccine manufacturing process are identical to the 
one which they all originate from, master seed bank.
The sequence of the working seed bank showed no 
nucleotide substitutions in passaged viruses from the 
sequence of the Sofjin-Chumakov from the master seed 
bank. Sequences of structural part of the non-concen-
trated bulk genomes were identical to the one from the 
master seed bank virus.
Sanger’s method of sequencing does not allow detect-
ing up to 10  % of the admixture, genetically different 
from the master-sequence. The TBE vaccine Moscow 
is an inactivated vaccine, so the main role in the vac-
cine potency goes to inactivated virion antigen, which 
includes structural proteins  only. More than 85–90  % 
identity of the structural proteins (antigen) throughout 
the manufacturing process is enough to imply the anti-
genic stability of the virus through the manufacturing 
process in the case of the inactivated vaccine.
Conclusions
In the present work, we first described the genome of the 
TBEV strain Sofjin, which has the longest history as a 
vaccine strain, and then provided evidence of its stability 
during the manufacturing process.








































































































Fig. 1 Phylogenetic tree of complete genome sequences of TBEV strains (NJ method). Strain Sofjin-Chumakov is shown in bold, other “Sofjin” strains 
are shown in bold italics































































































Fig. 2 Phylogenetic tree of Far-Eastern TBEV subtype for fragment genome sequences for E protein, including all “Sofjin” strains (shown in bold) (NJ 
method)
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